David is currently an Assistant Professor at The Chinese University of Hong Kong. He obtained his medical degree from The University of Hong Kong in 2010 after completing his overseas elective training at the University of Cambridge Addenbrooke's Hospital, and St Thomas' Hospital, King's College London.

During his Neurosurgery Fellowship training, David was awarded the Best Research Award for two consecutive years from the College of Surgeons of Hong Kong (CSHK) in 2016 and 2017. He completed the training in 2018 with a Distinction in his Higher Surgical Training Research Project and was awarded the Best Original Paper Award in 2019 from CSHK.

David is a Council member of the Hong Kong Neurosurgical Society. He is active in both research and teaching. His research interests are endoscopic surgery and minimally invasive surgical techniques in Neurosurgery, head and spine injury.

Emily is a 2008 Medical Graduate and acquired a Master degree in Neuroscience in 2014 from The Chinese University of Hong Kong (CUHK). She was qualified as a specialist neurosurgeon in 2016. She subspecialises in Paediatric Neurosurgery. She is an Associate Consultant serving both Prince of Wales Hospital and Hong Kong Children's Hospital. She is also a Clinical Assistant Professor (Honorary) at Department of Surgery, CUHK.

Carol obtained her bachelor and MPhil degrees from Department of Physics, The University of Hong Kong, followed by a PhD degree from School of Metallurgy and Materials Sciences, The University of Birmingham. She is currently an Associate Professor at Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong (CUHK).

Carol's research focus concerning ocular imaging technology is largely founded upon the concept of the eye as a "window" to the internal mechanisms of blood circulation and the nervous system. For more than 15 years, she has researched extensively on the development and application of image analysis techniques and artificial intelligence for investigating important diseases such as diabetic retinal disease, glaucoma, and Alzheimer's disease. Currently, she aims to bridge research related to AI with the possible implementation of AI technology to promote timely eye disease management and treatment through improving eye disease screening in primary care and eye disease triaging in tertiary clinics. This mission will have a significant influence on the people in Hong Kong and beyond by enhancing the quality and efficiency of clinical service. Notably, Carol played an influential role as part of an international team led by CUHK in developing the first ever AI model that incorporates fundus photography for the detection of Alzheimer's disease, which is predicted to play a significant role in screening for Alzheimer's disease in the community. She has published many landmark papers on the development of AI-based technologies within the field of ocular imaging for the detection of many eye diseases and quantitative analysis to investigate the use of optical coherence tomography angiography for the assessment of diabetic microvascular diseases. Carol has authored more than 250 original research papers with an H-index of 55 and citations more than 11700.

Dr Chou is the Chief of the Spine Division, Professor and Vice Chair of Neurosurgery at the Columbia University Vagelos College of Physicians and Surgeons and New York Presbyterian/Columbia University Irving Medical Center. Dr. Chou has many years o

Aya is a tenure-track Clinical Assistant Professor at Department of Clinical Oncology, Li-Ka Shing Faculty of Medicine, The University of Hong Kong. She was conferred the MB BCh BAO degree from the National University of Ireland Galway in 2008 and graduated with first-class honors and gold medals in the fields of Medicine and Surgery. She was awarded the Sir Allen McClay Clinical Research Fellowship at the Stratified Medicine Group and conferred a PhD by Queen's University Belfast in 2018. Her PhD focused on stress-activated kinases, biomarker development, and early drug development. She is a Medical Oncologist and Physician-Scientist and has extensive experience in translational research, biomarker development, and cancer genomics. Her subspecialty areas are neuro-oncology, melanoma, and GI tract cancers. She is the principal investigator of several biomarker-driven first-in-human and early-phase trials. Aya has been newly appointed as the President of the Hong Kong Neuro-Oncology Society.

Dr Fehlings is Professor of Neurosurgery, the Vice Chair Research for the Department of Surgery at the University of Toronto and Co-Director of the University of Toronto (U of T) Spine Program. He is also the Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration, a Scientist at the McEwen Centre for Regenerative Medicine, and a McLaughlin Scholar in Molecular Medicine. His main clinical interests are spinal neurosurgery, and his research focus is in molecular mechanisms underlying spinal cord injury.

Dr Fehlings received his medical degree from the U of T in 1983. Following a surgical internship at Queen's University in 1983-84, he entered the U of T Neurosurgical Training Program in 1984. During his residency, he had pursued a PhD degree in 1989 in the Institute of Medical Sciences for his work on experimental spinal cord injury. He undertook a post-doctoral research fellowship under Dr Wise Young and a clinical spine fellowship under Dr Paul Cooper at NYU Medical Center. Dr Fehlings became a Fellow of the Royal College of Physicians and Surgeons of Canada in 1990 and a Fellow of the American College of Surgeons in 2006. In 1991. He joined the Neurosurgical Staff at the Toronto Western Hospital in 1992.

The Fehlings Lab is a world leader in the field of translational research dedicated to neural repair and regeneration. Dr. Fehlings and his team have published over 900 peer-reviewed articles on topics such as traumatic spinal cord injury, degenerative cervical myelopathy, spine oncology, cerebral palsy and therapeutic treatments to repair and regenerate the injured central nervous system. Dr Fehlings has received numerous prestigious awards including the Olivecrona Award (2009) from the Karolinska Institute in Stockholm, Sweden (known as the "Nobel Prize of Neuroscience") for his important contributions in spinal cord injury and the H Richard Winn Award from the Society of Neurological Surgeons, which is the highest honor for academic neurosurgeons in North America.

Vincent is a 2003 Medical Graduate of The Chinese University of Hong Kong (CUHK). He was trained in general medicine (MRCP 2008, FHKAM 2013), and more recently, critical care medicine (2020) awarded FRCP (Edinburgh 2022 and Glasgow 2023). He did overseas training in stroke medicine in UCLA in 2013. Having one further training in neurology in 2014-5, he was promoted to Associate Consultant at Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital, and Clinical Associate Professor (Honorary) at CUHK.

Owen holds Bachelor of Medical Sciences (BMedSc), and Bachelor of Medicine and Bachelor of Surgery (MBChB) from The Chinese University of Hong Kong (CUHK). He pursued a PhD in neuroscience at University College London (UCL), where he revealed several fundamental rules governing the connectivity between neurons with different functional roles in the brain. Owen currently holds joint appointments at Department of Medicine and Therapeutics, School of Biomedical Sciences and Department of Psychiatry, Faculty of Medicine, CUHK. He also serves as a principal investigator at the Li Ka Shing Institute of Health Sciences, and Associate Director for the Margaret K.L. Cheung Research Centre for Management of Parkinsonism of CUHK. Leading a team with expertise in biology, chemistry and engineering, Owen's current research works focus on, (i) gliovascular dysfunction in neurodegeneration, and (ii) development of imaging tools for translational and systems neuroscience. His research works had been recognised by a runner-up award of the 2014 Eppendorf & Science Prize for Neurobiology, a 2020 Croucher Innovation Award, a 2021 Excellent Young Scientist Fund (Hong Kong and Macau) from the National Natural Sciences Foundation of China, and the 2022 Sir David Todd Lectureship.

Ka-Wai received his bachelor and MPhil degrees in Engineering from Department of Automation and Computer-aided Engineering, The Chinese University of Hong Kong in 2003 and 2005 respectively. He obtained the PhD degree from the Hamlyn Centre for Robotic Surgery, Department of Computing, Imperial College London in 2012. Prior to joining The University of Hong Kong (HKU) in 2014, he was awarded the Croucher Foundation Fellowship, which supported his research jointly supervised by advisors in The University of Georgia, and Brigham and Women's Hospital, Harvard Medical School. His research interests focus on surgical robotics, intra-operative image processing, and their uses of intelligent systems. He has participated in various designs of robotic devices/interfaces for endoscopy, and MRI-guided interventions.

Ka-Wai is currently an Associate Professor at Department of Mechanical Engineering, HKU. To date, he has co-authored more 135 peer-reviewed articles with more than 80 clinical fellows and 150 scientists/engineers. His multidisciplinary work has been recognised by more than awards in international conferences/journals, such as the largest flagship conferences of robotics, ICRA and IROS. He was the recipient of ICRA Best Conference Paper Award in 2018, and IROS Toshio Fukuda Young Professional Award in 2020. He also obtained awards in his early career for robotics: the Early Career Awards 2015/16 offered by Research Grants Council (RGC) of Hong Kong, Actuators 2020 Young Investigator Award, HKU 2019-2020 Outstanding Young Researcher Award and HKU Young Innovator Award 2020.

Being a IEEE Senior Member, Ka-Wai serves editor boards for IROS 2017-22, ICRA 2019-21, IEEE Robotics and Automation Magazine (RAM), as well as Annals of Biomedical Engineering (ABME) and Proc. IMechE Part I: Journal of Systems & Control Engineering (JSCE). He is the principal investigator of group for Interventional Robotic and Imaging Systems (IRIS) at HKU. The group has more than 5 inventions licensed/transferred from university to industry in support for their commercialization. He is a co-founder of Agilis Robotics Ltd. aiming at advancing the interventional endoscopy with small, flexible robotic instruments and their intelligent control systems

Hei-Ming is a clinician-scientist in training working on the development of next generation 3D histology methods for advanced biomedical research and clinical applications. His team uses innovative chemical approaches - such as thermostabilization of antibodies - to achieve massively parallel organ-wide mapping of RNA transcripts and proteins, which is essential to gain a holistic correlation between tissue molecular composition, structural organization, and functional phenotypes.

Hei-Ming is a Clinical Assistant Professor at Department of Psychiatry, The Chinese University of Hong Kong. His foundational work on neuroscientific research tools have been published in leading journals as first and corresponding authors. His work has been awarded a Gold Medal in the 46th International Exhibitions of Inventions Geneva and Honourable Mention in Nikon Small World Photomicrography Competition.

Thomas is a Medical Graduate from The Chinese University of Hong Kong (CUHK) in 1995, trained locally in general medicine and neurology. He is now the Head of Division of Neurology, CUHK, awarded the Lee Quo-Wei Professorship of Neurology. He also serves as an Assistant Dean (Education) for Faculty of Medicine, CUHK.

Thomas Aims to translate science into health service. He is the first interventional neurologist in Hong Kong, and a Neuro-sonologist certified by American Society of Neuroimaging. He is also the national coordinator for Safe Implementation of Treatment in Stroke (SITS), council member in National Endovascular Treatment for Storke Committee, and Stroke Prevention and Risk Factor Control Committee, China, and the President of Hong Kong Neurological Society. His research interests in intracranial atherosclerosis, stroke imaging and cerebral re-vascularisation therapy have generated numerous competitive grants as principal investigators, overseas collaborations and private donations. He has published as the first or corresponding author in high-impact specialty journals including Annals of Neurology, Neurology, Stroke, JAMA Neurology, and Journal of Neurology, Neurosurgery and Psychiatry (JNNP). He is also reviewers, editorial board members and assistant/ associate editors of well-known international journals in stroke medicine and neurology.

Thomas's achievement in clinical service, teaching and research are phenomenal. A few important examples are CUHK Faculty of Medicine Best Teacher Award 2019, Outstanding Team Award 2019 as team leader of the Prince of Wales Hospital's acute stroke unit, Director of the Kwok Tak Seng Centre for Stroke Research and Intervention, Director of SHKP Kwok Brain Health Research Centre, collaborating with her sister centre, the Henry and Allison McCance Centre for Brain Health of MGH of Boston, doing impactful population based work, and Programme Co-director of a master programme in Stroke and Clinical Neurosciences, a popular course for health-care professionals.

Zheng received his bachelor and master degrees in Mechanical Engineering from Beihang University, China. After he obtained his PhD degree in Mechanical and Automation Engineering at The Chinese University of Hong Kong (CUHK), he joined the National University of Singapore as a research fellow. Currently, he is an Associate Professor at Department of Surgery, Multi-scale Medical Robotics Centre, Chow Yuk Ho Technology Centre for Innovative Medicine, and Li Ka Shing Institute of Health Sciences of CUHK.

Zheng's research interest mainly focuses on the area of intelligent bio-inspired medical robots including flexible surgical robots, magnetically actuated medical robots, and soft medical robots/devices. He is a senior member of IEEE, and a member of ASME, RAS, and EMBS. In the past years, he served as topic editor of Frontiers of Robotics & AI, IEEE BioRob, and associate editor of TMRB, RA-L, ICRA, IROS, RoboSoft and BioRob. In addition, he is a committee member of the conferences, Robio, ICIA, and CCECE, and a reviewer of journals including Advanced Sciences, Science Advances, IEEE TRO, SORO, IJRR, IEEE/ASME T-MECH, Cybernetics, TIE, Bioinspiration & Biomimetics, etc.

Zheng has authored over 130 peer-reviewed journal/conference papers, one book and three book chapters. He holds several patents/copyrights with two have been licensed. He received the Gold Awards of Emedic Global 2019, Silver Award of the 47th International Exhibition of Inventions Geneva, IEEE Robio 2022 Best Paper in Robotics, IEEE CCECE 2015 Conference Paper Award, Best Paper Finalist of IEEE Robio 2012, and Best Poster Finalist of IEEE ICRA 2017. His research projects are mainly supported by Research Grant Council and Innovation and Technology Commission of Hong Kong.

H.K. is Chair Professor at CUHK. His interests are in the molecular pathology of brain tumours, both adult and paediatric. H.K. is both a neuropathologist and general pathologist. He is an Associate Editor of Laboratory Investigation and an Associate Editor of Neuro-Oncology Advances, and is also on the Editorial Boards of Acta Neuropathologica, Brain Pathology, Glioma, Neuropathology and Applied Neurobiology, Clinical Neuropathology, and Pathology. He was a member of the Consensus Group of the 2007 and 2016 WHO classifications of the brain tumours. He is also a member of cIMPACT-NOW, which is an extension of The WHO classification. And for the WHO 2021 Classification, he is one of the only 10 neuropathologists from around the world to have been selected for the Consensus Group.

H.K. was part of the team who received The 2nd Tier Award of The National Science and Technology Award of China in 2010 and the First Tier Science and Technology Award of Shanghai in 2019. He received the International Academy of Pathology Gold Medal twice in 2006 and 2017, and the HMRF Research Award of the Hong Kong Department of Health in 2021.

Professor Ourselin is a Professor of Healthcare Engineering and Head of the School of Biomedical Engineering & Imaging Sciences at King's College London. The School focuses on the development of innovative medical technologies by combining expertise in computer sciences, artificial intelligence (AI), physics, computational modelling, biomedical engineering, robotic, sensing, chemistry and more. It is uniquely embedded within St Thomas' Hospital and has a matrix structure combining technology research with clinical application. Alongside Guy's & St Thomas' NHS Foundation Trust, Professor Ourselin is leading the establishment of aMedTech Hub, located at St Thomas' campus. He is also Director of the Wellcome/EPSRC Centre for Medical Engineering and Deputy Director of the London Medical Imaging and Artificial Intelligence Centre for Value Based Healthcare.

Professor Ourselin has over 20 years of experience within academia and research organisations across three countries. He has published over 600 peer reviewed journal articles with more than 40,000 citations and H-index over 100, and raised over £60M as Principal Investigator. The contribution of his School and his leadership was acknowledged by a Queen's Anniversary Prize (2019, lead applicant).

Jan is a Consultant Neurologist and Clinical Neurophysiologist at Spinal Cord Injury Center of Balgrist University Hospital, Zurich. He is a medical graduate from Heidelberg University and a board-certified neurologist trained in Switzerland (Zurich and Bern). His clinical and research focus is on clinical neurophysiology and improved diagnosis of degenerative cervical myelopathy. He has a strong interest in neuropathic pain after spinal cord injury. Jan is a member of international guideline committees.

Andrew is a full-time Intensive Care Clinician and Researcher at The Alfred Intensive Care Unit (ICU), Melbourne. He completed his undergraduate medical education at the University of Auckland, followed by ICU training in New Zealand, the United Kingdom and Australia. After award of Fellowship, Andrew worked as a Consultant for many years in Queensland, while also completing a PhD in antibiotic pharmacokinetics.

Andrew's major academic interests include optimised drug prescribing in the critically ill, haemodynamic management in severe sepsis, acute kidney injury and renal replacement therapy, management of SAH and TBI, and critical care nutrition. He is involved in critical care research internationally as an Executive Member of the ANZICS Clinical Trials Group (CTG). He also a keen educator; instructing on many ICU courses, and is Chair of the Neurocritical Care Special Interest Group, CICM. Andrew is a Professor, and Co-Deputy Director of the Australian and New Zealand Intensive Care - Research Centre, Monash University.

Maggie graduated from The Chinese University of Hong Kong (CUHK) in 2008 and completed her paediatric training at Department of Paediatrics, Prince of Wales Hospital (PWH). She is a fellow in the Subspecialty of Paediatric Neurology, Hong Kong. She has undergone further postgraduate training with Professor Barry Rawicki in Paediatic Rehabilitation at Monash Children's Hospital, Melbourne, and with Professor Mark Mackay in Paediatric stroke and epilepsy at Royal Children's Hospital, Melbourne. She is currently an Associate Consultant at Department of Paediatrics, PWH and Clinical Assistance Professor (Honorary) of CUHK.

Dr. Zadeh is Dan Family Chair and Professor of Neurosurgery at University of Toronto. She is Head of the Department of Neurosurgery at Toronto Western Hospital and Co-Director for the Krembil Brain Institute at University Health Network. She is also a Senior Scientist at Princess Margaret Cancer Centre where she runs a translational research program at MacFeeters-Hamilton Neuro-oncology Program and holds the Wilkins Family Brain Tumor Research Chair.

Dr. Zadeh has a dedicated neuro-oncology and skull base practice, which includes a number of multidisciplinary specialized programs including a skull base clinic, brain metastases, pituitary clinic, and neurofibromatosis clinics. In parallel, she has an active research laboratory focusing on integrated multi-platform molecular analysis of brain tumors, together with a focus on understanding molecular response to targeted therapies, such as anti-angiogenesis and metabolic inhibitors. She is also involved in a number of national and international organizations. As past President of Society of Neuro-Oncology (SNO), she still holds responsibilities. She is Chair, Women in Neurosurgery Committee, WFNS also the Co-Chair and founder of the International Consortium on Meningiomas (ICOM) and Editor-in-Chief of Neuro-Oncology Advances, open access journal of SNO and EANO.